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Abstract
Background:  Lymphovascular ligation before tumour manipulation during colorectal cancer
resection is termed the 'no-touch isolation' technique. It aims to reduce the intra-operative
dissemination of colorectal cancer cells. Recently, the detection of circulating tumour cells has been
enhanced by molecular biology techniques. This paper reviews the evidence for the no-touch
isolation technique in light of the recent developments in circulating tumour cell detection.
Methods: Studies investigating the effect of colorectal cancer surgery on circulating tumour cells
were identified by a Medline search using the subject headings colorectal neoplasms and neoplasm
circulating cells together with the map term 'no-touch isolation technique'. Further references
were obtained from key articles.
Results: Molecular biological techniques have improved the detection of circulating colorectal
cancer cells. There is a trend towards reduced tumour cell dissemination with the no-touch
technique compared with the conventional method. However the benefit in terms of improved
patient survival remains unproven.
Conclusion: The no-touch isolation technique reduces circulating tumour cell dissemination but
further work is needed to determine the significance of this with regards to patient survival.
Background
Of the patients with colorectal cancer (CRC) undergoing
surgery for resectable disease, 30–50% will subsequently
develop metastases [1]. Dissemination of tumour cells is
therefore thought to occur early on in the disease process.
The principle of early lymphovascular ligation before
manipulation of the tumour during the surgical resection
of a CRC has been termed the 'no-touch isolation' tech-
nique. This was proposed by Barnes [2] as a way of reduc-
ing the incidence of liver metastases by diminishing the
intra-operative dissemination of CRC cells. An early pro-
ponent of the technique was Turnbull et al [3], but their
findings have not been confirmed in other studies [4].
Animal studies suggest tumour cells are shed into the cir-
culation during resection of a primary tumour, increasing
the likelihood of metastases [5]. However, the evidence in
humans is not clear. This may be because the early tech-
niques used to detect circulating tumour cells (CTC) were
not sufficiently sensitive to detect the small number of
cancer cells present within the blood. These detection
methods relied on cytological examination of blood
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smears, and allowed the detection of 1 tumour cell within
100 normal cells [6].
In recent years, the question of tumour cell dissemination
during surgical resection has been re-examined following
the introduction of molecular biology techniques to
detect CTC. These are much more sensitive, and it is now
possible to detect one tumour cell in a sample of 107 nor-
mal cells [7].
This paper reviews the evidence for the no-touch isolation
technique for the resection of a CRC in light of the recent
developments in molecular biological techniques for CTC
detection.
Methods
In performing this review, the studies looking at the effect
of CRC surgery on CTC were identified by a Medline
search using the subject headings colorectal neoplasms
and neoplasm circulating cells together with the map term
'no-touch isolation technique' [8-16]. Further references
were obtained from key articles [17-20].
We decided to review this topic by addressing three areas
of uncertainty. Firstly, does the surgical manipulation of a
CRC increase the level of tumour cells within the blood?
Secondly, what is the biological significance of CTC in
CRC? Thirdly, is the no-touch isolation technique of CRC
resection associated with an improved patient survival?
To investigate the effect of tumour manipulation on CTC,
we have reported the conversion, for each reviewed article,
of a negative preoperative blood sample (for CTC) to a
positive intra- or post-operative sample within the same
patient. We have only noted conversions within the same
sample source (systemic venous (SV) or portal venous
(PV) blood). Where conversion rates cannot be deter-
mined, as data for individual patients are not provided, a
comparison between overall preoperative and intra/post-
operative positivity for CTC is given. Unless otherwise
stated in the reviewed article, we have presumed the con-
ventional method was utilised (tumour manipulation
before lymphovascular ligation).
Results
A) Does the surgical manipulation of a CRC increase the 
level of tumour cells within the blood?
A number of experimental models have been used to
investigate the effect of surgical manipulation on CTC.
Nishitaki et al [5] studied 2 groups of rabbits with surgi-
cally-inoculated liver tumours. The first group had a
laparotomy and manipulation of the hepatic tumour 14
days after inoculation, together with resection of the
tumour. The second group had a laparotomy and resec-
tion of the tumour but without manipulation. Two weeks
later the rabbits were sacrificed, and pathological exami-
nation showed significantly more hepatic venous inva-
sion by cancer cells in the tumour manipulation group,
together with significantly more lung metastases and
shorter mean survival.
Romsdahl et al [21] measured the number of tumour cells
by cytological examination in blood samples from the
inferior vena cava of rats during manipulation of a thigh
tumour. There was a manifold increase in the number of
CTC during manipulation, which decreased rapidly, so
that 4 minutes after manipulation 93–96% of the cells
had disappeared from the circulation. In a similar experi-
ment with mice, Liotta et al [22] showed a 10-fold
increase in tumour cells in the venous effluent of a thigh
tumour during manipulation.
In order for the no-touch technique to be effective in
humans, early ligation of the main pedicle must eliminate
passage of liberated tumour cells into the portal and sys-
temic circulations. However, Salsbury et al [23] found the
number of tumour cells in the common iliac vein dramat-
ically increased after ligation of the inferior mesenteric
vein, suggesting there was a shift of the draining venous
blood into the systemic circulation following ligation. In
an experimental model using dogs, Ackerman [24]
showed clamping of the mesenteric veins produced an
increased intestinal lymphatic and venous outflow,
thereby enhancing the possibility of tumour cell dissemi-
nation. He concluded ligation of the major arterial sup-
ply, followed by the marginal vessels, is the most effective
technique in minimising outflow.
On theoretical grounds, the no-touch technique would
appear unsuitable for low rectal cancers, as it is necessary
to mobilise tumours in the rectum before all the draining
veins are controlled. In addition, a large proportion of the
venous drainage occurs into the iliac system, thereby
negating the effect of mesenteric pedicle ligation.
Results of reviewed articles
There have been numerous studies investigating the effect
of tumour manipulation on CTC in human tumours. This
review focuses on studies involving CRC. The overall con-
version rates for each study (ie conversion from negative
preoperatively for CTC to positive intra or post-opera-
tively taking into account all study patients) are listed in
Additional Files 1 and 2. The conversion rates taking in to
account only those patients negative preoperatively for
CTC are also listed.
The only study to compare directly the conventional and
no-touch techniques for the resection of a CRC involved
the non-random assignment of 27 patients into conven-
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allele-specific amplification (MASA) was used to identify
mutations of K-ras or p53 genes in the primary tumour of
each patient. Cells containing the same mutations were
then examined for in blood samples taken before, during,
and after surgery. In the conventional group, 11 patients
had K-ras or p53 mutations in their primary tumour.
None of these patients had preoperative blood samples
that contained cells exhibiting similar mutations. How-
ever, 8 (73%) did have cells containing similar mutations
in the blood taken intra-operatively following tumour
manipulation. In the no-touch group, 7 patients had
mutations in their primary tumour. None of these
patients showed similar mutations preoperatively, and
only 1 patient (14%) became positive intra-operatively.
From these findings, the authors conclude the no-touch
technique is effective at reducing the intra-operative dis-
semination of colorectal tumour cells.
The other studies involving CRC have used either the con-
ventional or no-touch surgical techniques, but have not
directly compared both. Weitz et al [9] and Sales et al [10]
employed the no-touch technique and found an overall
conversion rate of 16% and 9% respectively. Both studies
conclude the no-touch technique is effective at reducing
tumour cell dissemination. Bessa et al [17] also used the
no-touch technique in 50 patients who were randomly
assigned to undergo open or laparoscopically-assisted
colectomy. They found an overall conversion rate of 8%
and 12% respectively in SV samples.
Studies employing the conventional technique of CRC
resection have found overall conversion rates of 0 – 80%
in SV samples [11-15,18,19] (see Additional file 2).
Funaki et al [20] demonstrated the highest conversion,
with 4 out of a study sample of 5 patients converting intra-
operatively. This is much higher than in any other study,
and although the sample size is small, the authors suggest
this is evidence of tumour cell dissemination as a result of
surgical manipulation. It is interesting to note 80% of
these patients had rectal cancers, which require significant
mobilisation before control of the venous output is
obtained. Griffiths et al [18] did not detail individual
patients and so the conversion rate cannot be determined,
but they found 4% of patients were positive preopera-
tively, 50% were positive intra-operatively, and 8% post-
operatively. Similarly, Ito et al [15] found significantly
more patients were positive for CTC following surgery
compared with preoperatively (51% v 38%, p = 0.003).
Most authors conclude their results demonstrate evidence
of tumour cell dissemination. However, Garcia-Olmo et
al [11], who used the conventional technique and did not
demonstrate a conversion in any patients, concluded the
no-touch isolation technique was unnecessary.
As a number of patients were positive for CTC before sur-
gery, a more direct assessment of the effect of tumour
manipulation might be to analyse the conversion rates
only for those patients negative for CTC preoperatively.
This reveals a much greater conversion rate for most stud-
ies (see Additional Files 1 and 2). For example, using the
conventional method, Funaki et al [20] found all 4
patients negative preoperatively converted intra-opera-
tively. Similarly, Tien et al [13] demonstrated a conver-
sion of 49% for SV, and 52% for PV samples. Conversely,
Garcia-Olmo et al [11] used the conventional method and
failed to show conversion in any patients. For the no-
touch technique, the conversion rates are also greater if
only the patients negative preoperatively are considered.
Bessa et al [17] demonstrated the highest conversion rate,
with 50% and 33% of patients converting following lapar-
oscopically-assisted colectomy within SV and PV samples
respectively.
Limitations and variations of studies under review
1) Choice of technique used to detect CTC
Before the advent of molecular biology, the detection of
tumour cells within the blood depended on cytological
examination of a blood smear. The incidence of circulat-
ing tumour cells during CRC resection detected by cyto-
logical examination of blood smears has been reported as
25–67% [25,26]. Griffiths et al [18] state it is easy to
detect CTC within a blood sample, but this method of
detection underestimates the true number of circulating
cells as there is probably a considerable loss in the prepa-
ration of blood cell concentrates. Also, difficulties in inter-
pretation arise when other large mononuclear cells
mimicking cancer cells are present.
Immunocytochemistry has been used to detect CTC in a
number of tumour types, including colorectal cancer [27].
This technique labels tumour cells with antibodies against
specific cell components that are not expressed in haemat-
opoietic cells. It has the advantages of preserving cellular
morphology and allowing identification of cell clusters,
an important drawback of molecular detection techniques
[28]. It also permits simultaneous assessment of other cel-
lular details such as proliferation activity and oncogene
expression. However, it is labour intensive due to the low
concentration of CTC. The sensitivity has also been ques-
tioned [29], although this can be enhanced with flow
cytometry.
In recent years, molecular biological techniques have
been developed for use in tumour cell detection. The
polymerase chain reaction (PCR) involves detection and
amplification of certain DNA mutations. A copy of the
DNA containing the target sequence is made and the proc-
ess is repeated many times, producing multiple copies and
thereby increasing the sensitivity of detection. MutationsInternational Seminars in Surgical Oncology 2005, 2:5 http://www.issoonline.com/content/2/1/5
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in the k-ras gene have often been used for detection of
CTC in CRC.
However, the detection of these sequences within the
blood does not necessarily imply there are circulating
tumour cells, as DNA is relatively stable and may repre-
sent fragments of tumour DNA released by cell necrosis or
apoptosis and persisting in the blood for some time [30].
Also, this method of detection relies on the presence of
specific DNA mutations within the primary tumour, and
the genetic changes associated with CRC are known to be
heterogenous [28].
An alternative technique, now more commonly
employed, is reverse transcriptase-PCR (RT-PCR). This
detects messenger RNA (mRNA), which is used as an indi-
cator of tissue-specific gene transcription. The technique is
rapid, more easily automated than immunocytochemis-
try, and is capable of detecting one tumour cell in 107 nor-
mal cells [19]. RNA is rapidly degraded and so its presence
in the blood suggests active expression by circulating
tumour cells [13].
However, there is a lack of standardisation of RT-PCR
techniques, resulting in different sensitivities and specifi-
cities between centres [31]. Illegitimate transcription
(when tissue-specific genes are transcribed in non-specific
cells) can occur, and the presence of non-malignant epi-
thelial cells in the blood (for example, following
venepuncture [32]) reduces the specificity. RT-PCR detects
the number of copies of mRNA, not the number of CTC,
so it may not accurately assess an increase in tumour cells
secondary to mobilisation [13]; also it may be difficult to
derive the prognostic value of CTC if the levels cannot be
accurately determined in individual patients. False nega-
tives can occur with RT-PCR, affecting the technique's sen-
sitivity. The marker of interest may not be expressed
because of tumour cell heterogeneity or because there is a
poorly-differentiated subclone that has lost the ability to
express the tissue-specific marker [33]. PCR inhibitors
may be present within some body tissues, and it is impor-
tant to note the in-vitro sensitivity reported in the reviewed
articles will be higher than the true in-vivo sensitivity, as
the cell lines used to determine the sensitivity are known
to express strongly the marker of interest and are not
affected by the presence of in-vivo PCR inhibitors.
Most of the reviewed articles that state the specificity of
their technique claim a rate of 100%, indicating all the
tumour samples were positive for the marker of interest,
whereas none of the control blood samples (from healthy
volunteers or patients undergoing resection for benign
disease) were positive. However, Patel et al [14] examined
143 control subjects and found 7 (5%) were positive
when a single blood sample was assessed for CTC.
2) Choice of marker used to detect CTC
There are no tumour-specific genes for CRC, and it is
known malignant cells continue to express markers that
are characteristic of their tissue of origin. Therefore, a
range of epithelial cell markers, which are normally
absent from the blood, have been used as RT-PCR targets
for cancer cells derived from epithelial tissues.
The cytokeratin (CK) polypeptides are found within the
cytoplasm of epithelial cells, and several CK markers have
been used to detect CTC. The most common of these is CK
20, which is expressed in gastrointestinal epithelia,
urothelium, Merkel cells, and tumours derived from these
tissues [9]. Carcinoembryonic antigen (CEA) is a glyco-
protein found on the surface of epithelial cells. It is over-
expressed in nearly all colorectal cancers [34], as well as
other tumours such as breast and non-small cell lung car-
cinoma, and has been widely used to detect CTC. Guany-
lyl cyclase C (GCC) is another tissue-specific marker only
expressed in normal intestinal mucosa. It is a member of
the guanylyl cyclase family of receptors, and its expression
persists once the epithelial cell has undergone neoplastic
transformation [13]. Cell surface sialylated carbohydrates,
such as sialyl Lea and sialyl Lex, are associated with CRC
formation and progression [35], and have been used to
detect disseminated tumour cells as well as predict prog-
nosis.
Concerns regarding marker specificity have been raised.
CK 8, 18 and 19 have all been shown to be expressed in
normal blood [29]. CK 20 and CEA are more specific,
although they have also been seen in control samples
[31,36]. The CEA family includes homologous genes
expressed in granulocytes [37], and CEA may be induced
by surgical stress [15] as well as occurring in the blood of
patients with inflammatory conditions such as colitis
[38]. GCC appears to be the most specific marker investi-
gated. Bustin et al [31] found CK 20 transcripts in all 21
healthy volunteers studied, whereas GCC was found in
only a single control.
3) Choice of blood sample used to detect CTC
The source of blood for analysis appears to be important.
Most studies have investigated systemic venous samples
for the presence of CTC. Animal studies suggest tumour
cells become trapped in the capillary bed of the first organ
encountered [39,40], and so for CRC would be seen in the
liver but not in peripheral blood. Theoretically, CRC cells
must pass through the liver, lungs and the microcircula-
tion of the other tissues of the body before they pass into
the systemic venous circulation. Also, any CTC should be
diluted by the larger blood volume of the peripheral circu-
lation [12]. There should be many more circulating color-
ectal tumour cells in the portal circulation than the
systemic circulation, therefore. Griffiths et al [18] foundInternational Seminars in Surgical Oncology 2005, 2:5 http://www.issoonline.com/content/2/1/5
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57% of patients were positive for CTC in PV blood during
resection a colorectal tumour, as opposed to 50% of
patients who were positive in their SV samples. Tien et al
[13] found more PV samples were positive before, during
and after surgery compared with SV samples. However, 3
of the 17 who were positive in the peripheral blood were
negative in all portal samples, suggesting tumour cells
were bypassing the portal circulation and entering the sys-
temic circulation directly. It is interesting to note these 3
patients had Dukes stage C disease and it may be that
tumour cells were passing directly from the lymphatics
into the peripheral circulation. Bessa et al [17] found there
was concordance between SV and PV samples for CEA
mRNA in only 65% of cases. They also found no patients
demonstrated a conversion in PV samples following open
colectomy, however 8% converted in SV blood.
Due to the discrepancy in sample sources, we have only
noted patients who converted within the same venous
compartment. Several studies detected CTC in draining
vein blood intra-operatively, and compared it against a
reference SV sample taken before manipulation. It is diffi-
cult to be certain of conversion in these patients, however,
as it is possible the PV samples were positive preopera-
tively. It is important for subsequent studies to measure
CTC in both systemic venous and draining vein blood,
before, during and after tumour manipulation to investi-
gate further the discrepancy in CTC detection between the
venous compartments.
The importance of multiple sampling should be consid-
ered. Glaves et al [41] suggests cancer cells are intermit-
tently shed in to the blood, so sampling errors may occur
if single samples are taken. Tien et al [13] sampled SV and
PV blood twice during tumour mobilisation and found
that of the 14 patients who were positive in portal blood
during mobilisation, 5 (36%) were only positive in the
second sample, and so would have been considered nega-
tive if a single sample was taken. In the SV samples, 3 out
of 17 (18%) patients were only positive in the second
sample. Mori et al [19] also performed sequential sam-
pling intra-operatively, and found of the 5 patients posi-
tive for CTC at any of the 4 sampling time points, 2 (40%)
were positive at a single time point only. Wharton et al
[42] showed by increasing the sampling frequency (from
once to twice), the detection of CTC is significantly
increased.
Weitz et al [9] suggest another factor affecting the detec-
tion of CTC may be the degree of intra-operative blood
loss and subsequent administration of intravenous fluids,
thereby diluting the blood volume and reducing the like-
lihood of tumour cell detection. They showed the chance
of intra-operative detection of tumour cells was halved by
a blood loss of 0.5 l, and so excluded all patients with an
intra-operative blood loss of more than 1 l from further
statistical analysis. They found of the 7 patients who were
positive pre- or post- but not intra-operatively, 5 (71%)
had a blood loss of more than 1 litre, suggesting a possible
dilution effect during the operation. In the articles
reviewed, the degree of blood loss was only reported in
the study by Weitz et al.
B) What is the biological significance of CTC in CRC?
The detachment of malignant cells from the primary
tumour is an early step in the formation of metastases [5].
The release of tumour cells is a continuous process [43],
however the metastatic process is inefficient and the pres-
ence of tumour cells within the blood does not necessarily
imply the subsequent development of metastases [44]. It
is poorly understood which steps in the metastatic process
are responsible for the inefficiency of tumour cells to form
overt metastases.
Early studies suggested fewer than 0.1% of circulating
tumour cells survive in the circulation [39], and only
0.01% form metastases [45]. It was thought the majority
of CTC are removed from the circulation within 24 hours
[39], by elimination in the first capillary bed they encoun-
ter [46]. However, recent work using cytoplasmically-
labelled tumour cells (as opposed to nuclear-labelled cells
which are more vulnerable to destruction) has found the
majority of cells survive in the circulation for several days
following injection, and the inefficient part of the meta-
static process appears to be the variable growth of the can-
cer cell at the secondary site [47].
The metastatic process may be enhanced by the surgical
procedure itself. It is known the entrapment of tumour
cells in the microcirculation of a target organ is facilitated
by the presence of fibrin and platelets [48,49]. The activa-
tion of coagulation that occurs during an operation may
therefore augment this process [50]. Also, surgical stress
has been shown to induce immune suppression [51],
thereby increasing the metastatic efficiency.
The prognostic value of CTC in CRC has yet to be fully
determined. Fujita et al [52] found patients negative pre-
operatively for CK-19 or CK-20 had significantly fewer
recurrences and better 5-year disease free survival. Naka-
goe et al [53] found a high sialyl Le (x) antigen or CEA in
blood draining the tumour was an independent prognos-
tic indicator of poor survival, and Yamaguchi et al [12]
found a similar finding in patients positive for both CEA
and CK-20. Other studies show conflicting results, how-
ever. Bessa et al [54] found a preoperative peripheral
blood sample positive for CEA did not predict prognosis,
and in a comprehensive review, Tsavellas et al [29] con-
clude, at present, the presence of CTC cannot be consid-
ered to be a reliable indicator of prognosis in anyInternational Seminars in Surgical Oncology 2005, 2:5 http://www.issoonline.com/content/2/1/5
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common solid malignancy because of the lack of large
standardised trials with sufficient follow up.
C) Is the no-touch isolation technique of CRC resection 
associated with an improved patient survival?
There are few studies directly comparing the outcomes fol-
lowing conventional and no-touch techniques. Turnbull
et al [3] retrospectively compared 664 patients who
underwent CRC resection using the no-touch technique
against 232 patients with similar histological stage oper-
ated on by different surgeons employing the conventional
method. They found the overall 5-year survival rate for the
no-touch group was 51%, compared with 35% for the
conventional group. They state the difference in mortality
was due to an increased incidence of hepatic metastases in
the conventional group. Subsequent criticism [4] of Turn-
bull's findings suggested patient selection may not have
been random, and the basis of the no-touch technique
incorporates an extended lymphadenectomy. The study
also excluded cancers of the rectum.
Wiggers et al [4] randomly assigned 236 patients with
tumours of the colon or rectum to a no-touch or conven-
tional surgery group, and found no significant difference
between the groups in terms of recurrence or survival.
However, there was a trend towards fewer and later onset
of liver recurrences in the no-touch group. Their recom-
mendation was that the no-touch technique should be
used for tumours where it is easily applicable.
The largest series was reported recently by Slanetz [55],
who retrospectively reviewed 1863 cases of colorectal can-
cer resection over a period of 24 years. In 1050 cases,
tumour mobilisation had occurred before regional
mesenteric vessel ligation, whereas 813 cases had vessel
ligation performed initially. The extent of mesenteric
resection and tumour differentiation was reportedly simi-
lar between the two groups. The author reports the
sequence of vessel ligation had little impact on the inci-
dence of cancer-related deaths at 5 and 10 years, with no
significant difference in survival rates between the early
vessel ligation and conventional groups for colonic or rec-
tal tumours. However, the sequence of vessel ligation did
have a significant effect on the distribution of metastases.
The early vessel ligation group was associated with fewer
liver metastases but more systemic metastases compared
with the conventional group. These findings may support
the theory that after mesenteric pedicle clamping, there is
a shift in draining blood into the systemic circulation
[23]. There was also a significant increase in the local
recurrence rate with the no-touch compared with the con-
ventional technique (22.6% v 14.6%; p = 0.0001).
Another component of the no-touch isolation technique
investigated by Slanetz is the control of intraluminal
spread of malignant cells by applying bowel clamps or lig-
atures before tumour manipulation. He reviewed the
results of 599 CRC resections in which bowel ligation
prior to tumour mobilisation was used, and compared the
data against 1416 resections in which bowel ligation was
not performed. He found the application of bowel liga-
tures before tumour mobilisation significantly improved
the 5-year cancer-related death rate for colon cancer (20%
v 25%, p = 0.02), but not for rectal cancer. When consid-
ering colon and rectal cancer combined, bowel ligation
prior to mobilisation significantly reduced the local (12%
v 19%, p = 0.02) and distant (liver: 10% v 15%, systemic:
13% v 18%, p < 0.001) recurrence rates compared to
resection without prior bowel ligation. These findings
support the earlier work by Cole et al [56], who showed
that ligatures around the bowel controlled the rate of local
lymphatic and intraluminal dissemination of malignant
cells.
Conclusion
It is difficult to draw any firm conclusions from the arti-
cles studied due to the lack of standardisation of sample
source, CTC detection method and the small sample sizes.
However, the only study directly comparing conventional
and no-touch surgical techniques found a conversion rate
of 73% for conventional surgery and 14% for the no-
touch technique, suggesting a benefit of vascular clamp-
ing before tumour mobilisation. The overall conversion
rates for the other studies employing the no-touch tech-
nique were 0–16% (see Additional file 1), compared with
0–80% for studies utilising conventional surgery (see
Additional file 2). Therefore, these data suggest there is a
trend towards reduced tumour cell dissemination for the
no-touch isolation method. The benefit of this in terms of
improved patient survival, however, remains unproven.
On purely theoretical grounds, the presence of alternate
lymphovascular pathways for most colorectal tumours
ensures complete isolation of the tumour-bearing seg-
ment is hard to achieve, limiting the technique's efficacy.
In addition, the extent of mesenteric resection, and not
the surgical technique employed, is probably the most
important determinant of patient outcome following
CRC surgery [55].
Due to the lack of consensus regarding the best technique
for detection, the biological importance of CTC has not
been fully determined. With the introduction of molecu-
lar biological techniques, the sensitivity for detection has
improved considerably. The hope is that accurate detec-
tion of occult circulating malignant cells would help to
stage the disease and predict prognosis, as well as monitor
the response to therapy and highlight early the possibility
of recurrence. However due to the differences in method-
ology and conclusions of studies investigating this area,International Seminars in Surgical Oncology 2005, 2:5 http://www.issoonline.com/content/2/1/5
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the detection of CTC cannot, at present, be used to dictate
therapeutic strategy.
Despite the methodological heterogeneity of the articles
reviewed, we believe the introduction of highly sensitive
methods of CTC detection has forced a re-analysis of the
role of the no-touch isolation technique in CRC surgery,
and the stages of CRC resection using the no-touch tech-
nique would appear to offer a sensible, systematic
approach to the surgical management of large bowel
tumours. However, further work needs to be done to
investigate the remaining areas of uncertainty. In particu-
lar, future developments in CTC detection must ensure
more automation and greater standardisation of tech-
niques between centres. RT-PCR appears to offer the great-
est sensitivity, and techniques detecting multiple markers
that are more tumour-specific should be investigated
[57,58]. The true biological importance of CTC in CRC
needs to be assessed further, and finally, the actual benefit
of the no-touch technique can only be determined by
large scale randomised clinical trials utilising multiple
venous sampling in patients matched for age and stage of
disease.
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